User talk:Beanie Bo: Difference between revisions

Line 63:

::----

::[[User:Beanie Bo|Beanie Bo]] ([[User talk:Beanie Bo|talk]]) 20:55, 28 October 2025 (UTC)

:::----

:::3. Licensing / Design Restrictions of Existing Manufactures (EU / UK Context)

:::*According to an expert report for the UK’s UK COVID‑19 Public Inquiry, existing ventilator manufacturers refused to grant licences of their approved designs to allow scale-up by third parties (for reasons including component shortages, liability concerns). ([https://covid19.public-inquiry.uk/wp-content/uploads/2025/03/04181843/INQ000539153.pdf?utm_source=chatgpt.com UK Covid-19 Inquiry])

:::*In effect, rather than sharing open designs or allowing mass third-party manufacture, many health-system actors found little scope to replicate validated ventilators rapidly. '''Key takeaway:''' The promise/hope of open access or broad manufacturing collaboration met resistance from proprietary design holders — limiting scale-up.

:::----

:::4. Design & Manual / Consumables Shortcomings (Imported Devices)

:::*As part of the UK inquiry: one supplier’s devices were delivered “with just two days of consumables necessary to use such ventilators and no information about future consumable supply” — meaning they were functionally unusable for extended patient care. ([https://ukcovid19inquiry.dracos.co.uk/module-5/2025-03-17/?utm_source=chatgpt.com UK Covid-19 Inquiry Transcripts]) '''Key takeaway:''' Technical and logistical details (manuals, consumables, servicing) often failed to match the headline promise of “ready to use”.

:::----

:::[[User:Beanie Bo|Beanie Bo]] ([[User talk:Beanie Bo|talk]]) 21:00, 28 October 2025 (UTC)

::: ----

:::3. ~~Licensing / Design Restrictions of Existing Manufactures~~ (~~EU / UK Context~~)

:::🔒 3. Ventilator Right-to-Repair Failures (Philips, Dräger, Hamilton, etc.)

:::* According to ~~an expert report for~~ the ~~UK’s UK COVID‑19 Public Inquiry, existing ventilator manufacturers~~ refused to ~~grant licences of their approved designs~~ to ~~allow scale-up by third parties (for reasons including component shortages~~, ~~liability concerns)~~. ~~([https~~:~~//covid19.public~~-~~inquiry~~.~~uk/wp-content/uploads/2025/03/04181843/INQ000539153~~.~~pdf?utm_source=chatgpt~~.~~com UK Covid~~-~~19 Inquiry]~~)

:::'''The claim:''' Manufacturers pledged to “do everything possible” to keep ventilators running during the crisis.

:::* ~~In effect~~, ~~rather than sharing open designs or allowing mass third-party manufacture~~, ~~many health-system actors found little scope to replicate validated ventilators rapidly~~. '''~~Key takeaway~~:''' The ~~promise/hope of open access or broad manufacturing collaboration met resistance from proprietary design holders — limiting scale~~-up.

:::'''Reality:'''

:::* Many refused to share repair manuals or software keys with hospitals.

:::* Philips and Dräger in particular restricted access to firmware updates, citing “liability and security.”

:::* Hospitals were forced to cannibalize parts or rely on gray-market servicing. '''Why it’s comparable:''' These companies didn’t frame it as open source, but they ''publicly signaled cooperation'' while continuing to enforce proprietary repair barriers — effectively undermining pandemic response. → Vice and Popular Mechanics ran exposés accusing them of “hoarding repair data during a global emergency.”

::: ----

:::🧠 4. Dyson (CoVent Project)

:::'''The claim:''' Build 10,000 new ventilators “within weeks” for the UK NHS.

:::'''Reality:'''

:::* No units were ever delivered to hospitals; the design never gained regulatory approval.

:::* Dyson claimed “we are ready,” but later internal documents (UK COVID Inquiry, 2025) showed there were known compatibility and safety concerns. '''Why it’s comparable:''' The company ''over-promised technological readiness'' to the public and government, despite the project being unproven. → This was more about '''engineering hubris''' than IP restriction, but the PR mismatch was just as stark.

::: ----

:::4. ~~Design & Manual~~ / ~~Consumables Shortcomings~~ (~~Imported Devices~~)

:::⚖️ 5. Newport / Covidien (Pre-Pandemic Project That Might Have Saved Lives)

:::* ~~As part of~~ the ~~UK inquiry~~: one supplier’s devices were delivered “with just two days of consumables necessary to use such ventilators and no information about future consumable supply” — meaning they were functionally unusable for extended patient care. ([https:~~//ukcovid19inquiry~~.~~dracos~~.~~co.uk/module~~-~~5/2025-03-17/?utm_source=chatgpt~~.~~com UK Covid-19 Inquiry Transcripts])~~ '''~~Key takeaway~~:''' ~~Technical and logistical details (manuals~~, ~~consumables~~, ~~servicing) often failed~~ to ~~match the headline promise of “ready to use”~~.

:::'''The claim (pre-2012):''' Newport Medical Instruments was developing a $3,000 ventilator under a U.S. pandemic preparedness contract.

:::'''Reality:'''

:::* Covidien (Medtronic’s parent company later) bought Newport in 2012 and canceled the project, citing “profitability concerns.”

:::* The U.S. government had to restart the program from scratch in 2014 — it was unfinished when COVID-19 hit. '''Why it’s comparable:''' Not a “pandemic promise broken,” but a '''strategic decision that crippled later emergency readiness''', closely tied to corporate consolidation and IP control.

::: ----

:::[[User:Beanie Bo|Beanie Bo]] ([[User talk:Beanie Bo|talk]]) 21:00, 28 October 2025 (UTC)

:::[[User:Beanie Bo|Beanie Bo]] ([[User talk:Beanie Bo|talk]]) 21:03, 28 October 2025 (UTC)

==Requesting fix on medical ventilators article - newline after stubnotice==

@@ Line 63: / Line 63: @@
 ::----
 ::[[User:Beanie Bo|Beanie Bo]] ([[User talk:Beanie Bo|talk]]) 20:55, 28 October 2025 (UTC)
+:::----
+:::3. Licensing / Design Restrictions of Existing Manufactures (EU / UK Context)
+:::*According to an expert report for the UK’s UK COVID‑19 Public Inquiry, existing ventilator manufacturers refused to grant licences of their approved designs to allow scale-up by third parties (for reasons including component shortages, liability concerns). ([https://covid19.public-inquiry.uk/wp-content/uploads/2025/03/04181843/INQ000539153.pdf?utm_source=chatgpt.com UK Covid-19 Inquiry])
+:::*In effect, rather than sharing open designs or allowing mass third-party manufacture, many health-system actors found little scope to replicate validated ventilators rapidly.  '''Key takeaway:''' The promise/hope of open access or broad manufacturing collaboration met resistance from proprietary design holders — limiting scale-up.
+:::----
+:::4. Design & Manual / Consumables Shortcomings (Imported Devices)
+:::*As part of the UK inquiry: one supplier’s devices were delivered “with just two days of consumables necessary to use such ventilators and no information about future consumable supply” — meaning they were functionally unusable for extended patient care. ([https://ukcovid19inquiry.dracos.co.uk/module-5/2025-03-17/?utm_source=chatgpt.com UK Covid-19 Inquiry Transcripts])  '''Key takeaway:''' Technical and logistical details (manuals, consumables, servicing) often failed to match the headline promise of “ready to use”.
+:::----
+:::[[User:Beanie Bo|Beanie Bo]] ([[User talk:Beanie Bo|talk]]) 21:00, 28 October 2025 (UTC)
 ::: ----
-:::3. Licensing / Design Restrictions of Existing Manufactures (EU / UK Context)
+:::🔒 3. Ventilator Right-to-Repair Failures (Philips, Dräger, Hamilton, etc.)
-:::* According to an expert report for the UK’s UK COVID‑19 Public Inquiry, existing ventilator manufacturers refused to grant licences of their approved designs to allow scale-up by third parties (for reasons including component shortages, liability concerns). ([https://covid19.public-inquiry.uk/wp-content/uploads/2025/03/04181843/INQ000539153.pdf?utm_source=chatgpt.com UK Covid-19 Inquiry])
+:::'''The claim:''' Manufacturers pledged to “do everything possible” to keep ventilators running during the crisis.
-:::* In effect, rather than sharing open designs or allowing mass third-party manufacture, many health-system actors found little scope to replicate validated ventilators rapidly.  '''Key takeaway:''' The promise/hope of open access or broad manufacturing collaboration met resistance from proprietary design holders — limiting scale-up.
+:::'''Reality:'''
+:::* Many refused to share repair manuals or software keys with hospitals.
+:::* Philips and Dräger in particular restricted access to firmware updates, citing “liability and security.”
+:::* Hospitals were forced to cannibalize parts or rely on gray-market servicing.  '''Why it’s comparable:''' These companies didn’t frame it as open source, but they ''publicly signaled cooperation'' while continuing to enforce proprietary repair barriers — effectively undermining pandemic response.  → Vice and Popular Mechanics ran exposés accusing them of “hoarding repair data during a global emergency.”
+::: ----
+:::🧠 4. Dyson (CoVent Project)
+:::'''The claim:''' Build 10,000 new ventilators “within weeks” for the UK NHS.
+:::'''Reality:'''
+:::* No units were ever delivered to hospitals; the design never gained regulatory approval.
+:::* Dyson claimed “we are ready,” but later internal documents (UK COVID Inquiry, 2025) showed there were known compatibility and safety concerns.  '''Why it’s comparable:''' The company ''over-promised technological readiness'' to the public and government, despite the project being unproven.  → This was more about '''engineering hubris''' than IP restriction, but the PR mismatch was just as stark.
 ::: ----
-:::4. Design & Manual / Consumables Shortcomings (Imported Devices)
+:::⚖️ 5. Newport / Covidien (Pre-Pandemic Project That Might Have Saved Lives)
-:::* As part of the UK inquiry: one supplier’s devices were delivered “with just two days of consumables necessary to use such ventilators and no information about future consumable supply” — meaning they were functionally unusable for extended patient care. ([https://ukcovid19inquiry.dracos.co.uk/module-5/2025-03-17/?utm_source=chatgpt.com UK Covid-19 Inquiry Transcripts])  '''Key takeaway:''' Technical and logistical details (manuals, consumables, servicing) often failed to match the headline promise of “ready to use”.
+:::'''The claim (pre-2012):''' Newport Medical Instruments was developing a $3,000 ventilator under a U.S. pandemic preparedness contract.
+:::'''Reality:'''
+:::* Covidien (Medtronic’s parent company later) bought Newport in 2012 and canceled the project, citing “profitability concerns.”
+:::* The U.S. government had to restart the program from scratch in 2014 — it was unfinished when COVID-19 hit.  '''Why it’s comparable:''' Not a “pandemic promise broken,” but a '''strategic decision that crippled later emergency readiness''', closely tied to corporate consolidation and IP control.
 ::: ----
-:::[[User:Beanie Bo|Beanie Bo]] ([[User talk:Beanie Bo|talk]]) 21:00, 28 October 2025 (UTC)
+:::[[User:Beanie Bo|Beanie Bo]] ([[User talk:Beanie Bo|talk]]) 21:03, 28 October 2025 (UTC)
 ==Requesting fix on medical ventilators article - newline after stubnotice==